JPS53121724A - Novel acetoamide derivatives - Google Patents

Novel acetoamide derivatives

Info

Publication number
JPS53121724A
JPS53121724A JP3540678A JP3540678A JPS53121724A JP S53121724 A JPS53121724 A JP S53121724A JP 3540678 A JP3540678 A JP 3540678A JP 3540678 A JP3540678 A JP 3540678A JP S53121724 A JPS53121724 A JP S53121724A
Authority
JP
Japan
Prior art keywords
novel
acetoamide
derivatives
acetoamide derivatives
novel acetoamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3540678A
Other languages
English (en)
Other versions
JPS629103B2 (ja
Inventor
Rafuon Rui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of JPS53121724A publication Critical patent/JPS53121724A/ja
Publication of JPS629103B2 publication Critical patent/JPS629103B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP3540678A 1977-03-31 1978-03-29 Novel acetoamide derivatives Granted JPS53121724A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB13579/77A GB1584462A (en) 1977-03-31 1977-03-31 N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them

Publications (2)

Publication Number Publication Date
JPS53121724A true JPS53121724A (en) 1978-10-24
JPS629103B2 JPS629103B2 (ja) 1987-02-26

Family

ID=10025527

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3540678A Granted JPS53121724A (en) 1977-03-31 1978-03-29 Novel acetoamide derivatives

Country Status (14)

Country Link
US (1) US4177290A (ja)
JP (1) JPS53121724A (ja)
BE (1) BE865468A (ja)
CA (1) CA1091679A (ja)
CH (1) CH628026A5 (ja)
DE (2) DE19875010I2 (ja)
DK (1) DK152207C (ja)
ES (1) ES468378A1 (ja)
FR (1) FR2385693A1 (ja)
GB (1) GB1584462A (ja)
IE (1) IE46566B1 (ja)
IT (1) IT1094041B (ja)
LU (2) LU79335A1 (ja)
NL (2) NL188692C (ja)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62190160A (ja) * 1986-01-31 1987-08-20 ラボラトワ−ル　エル　ラフオン （−）−ベンツヒドリルスルフイニルアセトアミド及びその製法
JPH0665070A (ja) * 1991-12-13 1994-03-08 Lab L Lafon Sa 脳組織を保護するためのモダフィニル
JP2004515458A (ja) * 2000-05-16 2004-05-27 セフアロン・インコーポレーテツド 置換チオアセトアミド
JP2005535698A (ja) * 2002-08-09 2005-11-24 セファロン フランス モダフィニル多形相
JP2006516560A (ja) * 2003-01-13 2006-07-06 オルガニザシオン ドゥ サンテーズ モンディアル オルシモン メチル２−ジフェニルメチルスルフィニルアセテートの調製方法
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
JP2006528966A (ja) * 2003-05-16 2006-12-28 オルガニザシオン ドゥ サンテーズ モンディアル オルシモン モダフィニル合成方法
JP2007505891A (ja) * 2003-09-19 2007-03-15 セファロン フランス 不斉酸化によるモダフィニルの単一エナンチオマーのエナンチオ選択的合成方法
JP2008505058A (ja) * 2004-04-13 2008-02-21 セフアロン・インコーポレーテツド チオ−置換ビアリールメタンスルティニル誘導体
JP2009024006A (ja) * 2000-07-27 2009-02-05 Teva Pharmaceutical Industries Ltd 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539404A (en) * 1980-06-19 1985-09-03 Petrolite Corporation Pyrimidines containing sulfur and amino groups as corrosion inhibitors
US4393026A (en) * 1980-06-19 1983-07-12 Petrolite Corporation Compounds containing sulfur and amino groups
US4332967A (en) * 1980-06-19 1982-06-01 Petrolite Corporation Compounds containing sulfur and amino groups
US4616085A (en) * 1980-06-19 1986-10-07 Petrolite Corporation Thioethers of imidazolines
US4450137A (en) * 1981-11-10 1984-05-22 Petrolite Corporation Processes for inhibiting corrosion using compounds containing sulfur and amino groups
US4684507A (en) * 1981-11-10 1987-08-04 Petrolite Corporation Process of corrosion inhibition using compounds containing sulfur and amino groups
US4450138A (en) * 1981-11-10 1984-05-22 Petrolite Corporation Processes for inhibiting corrosion using compounds containing sulfur and amino groups
FR2528038B2 (fr) * 1982-06-04 1985-08-09 Lafon Labor Derives de benzhydrylsulfinylacetamide et leur utilisation en therapeutique
FR2528039A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Nouveaux derives de benzylsulfinylacetamide, utilisation en therapeutique et procede de preparation
FR2528041A1 (fr) * 1982-06-04 1983-12-09 Lafon Labor Acides halogenobenzhydrylsulfinylacetohydroxamiques, procede de preparation et utilisation en therapeutique
FR2561646B1 (fr) * 1984-03-23 1987-10-09 Lafon Labor Derives d'acide (a-(alkylaminomethyl)-benzyl)-thioacetique, procede de preparation et utilisation en therapeutique
FR2584666B1 (fr) * 1985-07-10 1989-06-16 Champion Spark Plug Europ Bras moteur pour balai d'essuie-glace avec capuchon coulissant
FR2606015B1 (fr) * 1986-08-13 1989-05-19 Lafon Labor Derives du benzhydrylthiomethane, leurs procedes de preparation et leurs applications en therapeutique
FR2611709B1 (fr) * 1987-02-26 1989-06-09 Lafon Labor 2-(benzhydrylsulfonyl)acetamide, son procede de preparation et son application en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
JPH0421903U (ja) * 1990-06-18 1992-02-24
FR2697162B1 (fr) * 1992-10-23 1995-01-13 Lafon Labor Utilisation du modafinil pour la fabrication d'un médicament pour le traitement de l'incontinence urinaire et des troubles sphinctériens urétro vésicaux.
FR2706767B1 (ja) * 1993-06-22 1995-09-08 Lafon Labor
FR2708201B1 (fr) * 1993-06-30 1995-10-20 Lafon Labor Utilisation de dérivés d'acétamide pour la fabrication de médicaments.
FR2707637B1 (fr) * 1993-06-30 1995-10-06 Lafon Labor Nouveaux dérivés d'acétamide, leur procédé de préparation et leur utilisation en thérapeutique.
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
US6346548B1 (en) * 1999-08-16 2002-02-12 Cephalon, Inc. Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6455588B1 (en) 1999-08-20 2002-09-24 Cephalon, Inc. Compositions including modafinil for treatment of eating disorders and for appetite stimulation
CN1249932A (zh) * 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
FR2804322B1 (fr) * 2000-01-31 2002-04-19 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament destine a corriger les troubles de la vigilance associes aux myopathies
US6670358B2 (en) * 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
CN100584322C (zh) * 2000-10-11 2010-01-27 赛福伦公司 包含莫达非尼化合物的组合物
US6919378B2 (en) * 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7141555B2 (en) 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
IL143106A (en) * 2001-05-13 2005-11-20 Chemagis Ltd Process for the preparation of diphenylmethylthioacetamide
KR100911779B1 (ko) * 2001-05-25 2009-08-12 세파론, 인코포레이티드 모다피닐을 포함하는 고형 제약 제제
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
ITMI20020991A1 (it) * 2002-05-10 2003-11-10 Dinamite Dipharma S P A In For Procedimento per la sintesi del modafinil
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
TW200413296A (en) * 2002-08-09 2004-08-01 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
CN1305842C (zh) * 2002-12-31 2007-03-21 中国人民解放军军事医学科学院放射与辐射医学研究所 取代亚砜基乙酰胺的制备方法
WO2004075827A2 (en) * 2003-01-31 2004-09-10 Alembic Limited Process for the preparation of 2-[(diphenylmethyl) thio] acetamide
CA2420180A1 (en) * 2003-02-28 2004-08-28 Bernard Charles Sherman Tablets comprising modafinil
WO2004082630A2 (en) * 2003-03-17 2004-09-30 Neurohealing Pharmaceuticals, Inc. High potency dopaminergic treatment of neurological impairment associated with brain injury
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
ITMI20031298A1 (it) * 2003-06-26 2004-12-27 Erregierre Spa Processo di preparazione di modafinil forma polimorfa(i).
WO2005046854A2 (en) * 2003-09-12 2005-05-26 Sun Pharmaceutical Industries Limited A process for the preparation of diphenylmethylsulfinyl derivatives
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7345188B2 (en) * 2003-10-23 2008-03-18 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20050137264A1 (en) * 2003-12-22 2005-06-23 Patel Ashish A. Modafinil compositions
CN1980888B (zh) * 2004-02-06 2011-04-13 赛福伦公司 莫达芬尼组合物
EP1586561A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
EP1586559A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US20060024370A1 (en) 2004-07-29 2006-02-02 Cephalon France Modafinil oral lyophilizate
US20060086667A1 (en) * 2004-09-13 2006-04-27 Cephalon, Inc., U.S. Corporation Methods for the separation of enantiomeric sulfinylacetamides
CN100393699C (zh) * 2005-03-10 2008-06-11 浙江工业大学 2-（二苯基甲基亚硫酰基）乙酰胺的合成方法
EP1702915A1 (en) * 2005-03-14 2006-09-20 Cephalon France Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
CN1321978C (zh) * 2005-04-29 2007-06-20 浙江工业大学 一种2－（二苯基甲基亚硫酰基）乙酰胺的合成方法
US20090123545A1 (en) * 2005-07-21 2009-05-14 Ron Eyal S Rapid Onset and Short Term Modafinil Compositions and Methods of Use Thereof
US7994220B2 (en) 2005-09-28 2011-08-09 Cypress Bioscience, Inc. Milnacipran for the long-term treatment of fibromyalgia syndrome
ITMI20051971A1 (it) * 2005-10-18 2007-04-19 Dipharma Spa Procedimento per la preparazione di - modafinil
EP1973873A2 (en) * 2005-12-09 2008-10-01 Mallinckrodt Inc. Processes for the preparation of modafinil and analogs thereof
EP2056811B8 (en) * 2006-08-14 2018-03-21 Neurohealing Pharmaceuticals, Inc. Modafinil-based treatment for premature ejaculation
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
US9289403B2 (en) * 2007-03-09 2016-03-22 The Board of Trustees of the University of Arizona Use of modafinil to treat spasticity
WO2008149141A2 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
US8173169B2 (en) * 2007-07-11 2012-05-08 Hikma Pharmaceuticals Formulation and process for the preparation of modafinil
US7960586B2 (en) * 2007-08-16 2011-06-14 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
US20090082461A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched modafinil
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
US20110224196A1 (en) * 2010-01-07 2011-09-15 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
CN102976985A (zh) * 2011-09-07 2013-03-20 大连大学 一锅法合成二苯甲基亚磺酰基乙酰胺及其类似物的方法
US9862679B2 (en) 2013-03-08 2018-01-09 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
CN104341327A (zh) * 2013-08-08 2015-02-11 中国人民解放军63975部队 多卤素取代2-(二苯甲基亚硫酰基)乙酰胺类化合物及其立体异构体
CN104045588A (zh) * 2014-06-11 2014-09-17 江苏斯威森生物医药工程研究中心有限公司 一种2-(4,4’-二卤-二苯基甲基亚磺酰)乙酰胺的合成方法
CN104672118A (zh) * 2014-12-12 2015-06-03 上海泓海荣通医药技术有限公司 一种莫达非尼多晶体的合成方法
EP3391886A1 (en) 2017-04-19 2018-10-24 Novartis AG The use of a h3r inverse agonist for the treatment of shift work disorder
US11365195B2 (en) 2017-11-13 2022-06-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Atypical inhibitors of monoamine transporters; method of making; and use thereof
KR102126389B1 (ko) 2018-09-14 2020-06-25 셀라이온바이오메드 주식회사 벤즈히드릴티오 아세트아미드 화합물을 유효성분으로 포함하는 간 질환의 예방 또는 치료용 조성물
CN112789038A (zh) 2018-10-11 2021-05-11 诺华股份有限公司 H3r反向激动剂用于治疗与帕金森病(pd)相关的日间过度嗜睡的用途
KR102277739B1 (ko) 2019-12-11 2021-07-15 셀라이온바이오메드 주식회사 벤즈히드릴 티오 아세트아미드 화합물을 유효성분으로 포함하는 섬유화 질환의 치료용 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT336589B (de) * 1974-05-20 1977-05-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylderivaten
DE2546319C2 (de) * 1975-10-16 1986-02-27 Dr. Karl Thomae Gmbh, 7950 Biberach Cyclohexylphenyl-Derivate, Verfahren zu deren Herstellung und diese enthaltende Mittel
GB1574822A (en) * 1976-03-23 1980-09-10 Lafon Labor Acetohydroxamic acid derivatives and pharmaceutical compositions thereof

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62190160A (ja) * 1986-01-31 1987-08-20 ラボラトワ−ル　エル　ラフオン （−）−ベンツヒドリルスルフイニルアセトアミド及びその製法
JPH0665070A (ja) * 1991-12-13 1994-03-08 Lab L Lafon Sa 脳組織を保護するためのモダフィニル
JP2004515458A (ja) * 2000-05-16 2004-05-27 セフアロン・インコーポレーテツド 置換チオアセトアミド
JP2009024006A (ja) * 2000-07-27 2009-02-05 Teva Pharmaceutical Industries Ltd 結晶性の且つ純粋なモダフィニルおよびそれを製造する方法
JP2005535698A (ja) * 2002-08-09 2005-11-24 セファロン フランス モダフィニル多形相
JP4718177B2 (ja) * 2002-08-09 2011-07-06 セファロン フランス モダフィニル多形相
JP2011046730A (ja) * 2002-08-09 2011-03-10 Cephalon France モダフィニル多形相
JP2006516560A (ja) * 2003-01-13 2006-07-06 オルガニザシオン ドゥ サンテーズ モンディアル オルシモン メチル２−ジフェニルメチルスルフィニルアセテートの調製方法
JP4690304B2 (ja) * 2003-01-13 2011-06-01 セファロン フランス メチル２−ジフェニルメチルスルフィニルアセテートの調製方法
JP2006518754A (ja) * 2003-02-24 2006-08-17 マリンクロッド・インコーポレイテッド ベンズヒドリルチオアセトアミドの改良製法
JP2006528966A (ja) * 2003-05-16 2006-12-28 オルガニザシオン ドゥ サンテーズ モンディアル オルシモン モダフィニル合成方法
JP4825673B2 (ja) * 2003-05-16 2011-11-30 セファロン フランス モダフィニル合成方法
JP4713480B2 (ja) * 2003-09-19 2011-06-29 セファロン フランス 不斉酸化によるモダフィニルの単一エナンチオマーのエナンチオ選択的合成方法
JP2007505891A (ja) * 2003-09-19 2007-03-15 セファロン フランス 不斉酸化によるモダフィニルの単一エナンチオマーのエナンチオ選択的合成方法
JP2008505058A (ja) * 2004-04-13 2008-02-21 セフアロン・インコーポレーテツド チオ−置換ビアリールメタンスルティニル誘導体
JP4859828B2 (ja) * 2004-04-13 2012-01-25 セフアロン・インコーポレーテツド チオ−置換ビアリールメタンスルティニル誘導体

Also Published As

Publication number Publication date
DK140878A (da) 1978-10-01
JPS629103B2 (ja) 1987-02-26
LU79335A1 (fr) 1978-09-28
ES468378A1 (es) 1978-12-16
FR2385693A1 (fr) 1978-10-27
DK152207B (da) 1988-02-08
GB1584462A (en) 1981-02-11
DE19875010I2 (de) 2001-06-13
FR2385693B1 (ja) 1980-04-11
NL188692C (nl) 1992-09-01
DE2809625A1 (de) 1978-10-05
DE2809625C2 (de) 1985-05-09
CH628026A5 (fr) 1982-02-15
IE780433L (en) 1978-09-30
NL980003I2 (nl) 1998-05-06
NL980003I1 (nl) 1998-03-02
NL7803432A (nl) 1978-10-03
CA1091679A (en) 1980-12-16
US4177290A (en) 1979-12-04
IT1094041B (it) 1985-07-26
LU90153I2 (fr) 1998-02-16
IE46566B1 (en) 1983-07-27
DK152207C (da) 1988-07-11
IT7821872A0 (it) 1978-03-31
BE865468A (fr) 1978-10-02

Similar Documents

Publication Publication Date Title
JPS53121724A (en) Novel acetoamide derivatives
IL55387A0 (en) Triphenylalkene derivatives
AU4113878A (en) 1-alkanoyl-proline derivatives
GB2003876B (en) Beta-haloethylamine derivatives
GB1557019A (en) Metalsulphonamido-benzamide derivatives
JPS5392786A (en) Novel aminoalkoxyphenyl derivative
JPS53105529A (en) Novel phenyllbenzimidazolyleefuran
GB2008579B (en) 2-imino-imidazolidine derivatives
AU3888578A (en) 4-hydroxy-2-benzimidazolinone derivatives
GB2009180B (en) 25-alkylcholestrerol derivatives
GB2009150B (en) Tetrahydrophtalamide derivatives
HK28784A (en) Prostanol derivatives
GB2005261B (en) 2-oxazolydone derivatives
JPS53136000A (en) Novel naphthylidines
GB2014131B (en) 1-hydrocarbylpyrrole derivatives
GB2003479B (en) 3-amino-17alpha-aza-d-homoandrostane derivatives
AU3313978A (en) Everninomicin derivatives
GB2000128B (en) 15-substituted-omega-pentanorprostaglandin derivatives
GB2000769B (en) 4 - homoisotwistane derivatives
JPS5470300A (en) Novel substituted indolopyrones
AU3921578A (en) Novel 2-substituted-3-phenylindoles
GB2008119B (en) Arylsteroid derivatives
JPS53116381A (en) Novel pyridinee33ol
IL54973A0 (en) 3-pyridylhydroxy-prop-1-ene derivatives
AU4129978A (en) Eburnamenine derivatives